AGIO 总负债历史(2016–2025)
AGIOS PHARMACEUTICALS, INC. (AGIO) 各财年年末总负债(来自 SEC 财报)。
$104.1MFY2025 · FY2016 以来:$260.5M → $104.1M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $104.1M | -14.8% |
| FY2024 | $122.2M | -3.1% |
| FY2023 | $126.1M | -8.6% |
| FY2022 | $137.9M | -5.4% |
| FY2021 | $145.8M | -67.9% |
| FY2020 | $453.5M | +81.2% |
| FY2019 | $250.2M | +46.4% |
| FY2018 | $170.9M | -28.5% |
| FY2017 | $238.9M | -8.3% |
| FY2016 | $260.5M | — |
公司未直接申报总负债的年份,按同一财年年末的申报总资产 − 申报股东权益列示。
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议